Department of Cardiology Boston Children's HospitalHarvard Medical School Boston MA.
Pediatric Intensive Care Unit Department of Women's and Children's Health University of Padova Italy.
J Am Heart Assoc. 2022 Dec 6;11(23):e023963. doi: 10.1161/JAHA.121.023963. Epub 2022 May 10.
Background Left atrial (LA) decompression on extracorporeal membrane oxygenation (ECMO) can reduce left ventricular distension, allowing myocardial rest and recovery, and protect from lung injury secondary to cardiogenic pulmonary edema. However, clinical benefits remain unknown. We sought to evaluate the association between LA decompression and in-hospital adverse outcome (mortality, transplant on ECMO, or conversion to ventricular assist device) in patients who failed to wean from cardiopulmonary bypass using a propensity score to adjust for baseline differences. Methods and Results Children (aged <18 years) with biventricular physiology supported with ECMO for failure to wean from cardiopulmonary bypass after cardiac surgery from 2000 through 2016, reported to the ELSO (Extracorporeal Life Support Organization) Registry, were included. Inverse probability of treatment weighted logistic regression was used to test the association between LA decompression and in-hospital adverse outcomes. Of the 2915 patients supported with venoarterial ECMO for failure to wean from cardiopulmonary bypass, 1508 had biventricular physiology and 279 (18%) underwent LA decompression (LA+). Genetic and congenital abnormalities (=0.001) and pulmonary hypertension (=0.010) were less frequent and baseline arrhythmias (=0.022) were more frequent in LA+ patients. LA+ patients had longer pre-ECMO mechanical ventilation and CBP time (<0.001), and used aortic cross-clamp (=0.001) more frequently. Covariates were well balanced between the propensity-weighted cohorts. In-hospital adverse outcomes occurred in 47% of LA+ patients and 51% of the others. Weighted multivariate logistic regression showed LA decompression to be protective for in-hospital adverse outcomes (adjusted odds ratio, 0.775 [95% CI, 0.644-0.932]). Conclusions LA decompression independently decreased the risk of in-hospital adverse outcome in pediatric venoarterial ECMO patients who failed to wean from cardiopulmonary bypass, suggesting that these patients may benefit from LA decompression.
体外膜肺氧合(ECMO)可减轻左心房(LA)减压,减少左心室扩张,使心肌得到休息和恢复,并防止因心源性肺水肿引起的肺损伤。然而,临床获益仍不清楚。我们试图通过倾向评分来调整基线差异,评估在心脏手术后因心肺转流失败而无法撤离体外膜肺氧合的患者中 LA 减压与院内不良结局(死亡率、ECMO 上移植或转换为心室辅助装置)之间的关系。
本研究纳入了 2000 年至 2016 年期间因心肺转流失败而接受 ECMO 支持的伴有双心室生理功能的儿童(年龄<18 岁),并报告给 ELSO(体外生命支持组织)登记处。采用逆概率治疗加权逻辑回归检验 LA 减压与院内不良结局之间的关系。在 2915 例因心肺转流失败而接受静脉动脉 ECMO 支持的患者中,1508 例患者有双心室生理功能,279 例(18%)行 LA 减压(LA+)。LA+患者中遗传和先天性异常(=0.001)和肺动脉高压(=0.010)较少,而基线心律失常(=0.022)较多。LA+患者 ECMO 前机械通气和 CBP 时间较长(<0.001),且更常使用主动脉阻断钳(=0.001)。倾向性加权队列之间的协变量平衡良好。LA+患者中有 47%发生院内不良结局,而其余患者中有 51%发生。加权多变量逻辑回归显示 LA 减压可降低院内不良结局的风险(调整比值比,0.775 [95%CI,0.644-0.932])。
LA 减压可独立降低因心肺转流失败而无法撤离体外膜肺氧合的儿科静脉动脉 ECMO 患者的院内不良结局风险,表明这些患者可能受益于 LA 减压。